| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.46B | +3.7% |
| R&D Expense | $297.8M | -4.1% |
| SG&A Expense | $182.0M | -1.6% |
| Operating Income | $184.5M | +22.2% |
| Pre-tax Income | $204.0M | +11.5% |
| Income Tax | $58.4M | +16.6% |
| Net Income | $145.6M | +9.6% |
| EPS (Basic) | $2.30 | +16.8% |
| EPS (Diluted) | $2.24 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $216.1M | -0.6% |
| Short-term Investments | $103.3M | +2.7% |
| Accounts Receivable | $153.2M | -1.4% |
| Current Assets | $514.9M | -0.4% |
| Total Assets | $958.5M | -2.6% |
| Current Liabilities | $172.1M | +11.0% |
| Total Liabilities | $247.6M | +3.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $372.0M | +30.2% |
| Capital Expenditures | $48.4M | +29.5% |
| Investing Cash Flow | -$45.7M | +40.9% |
| Financing Cash Flow | -$330.0M | -8.6% |
| Free Cash Flow | $323.7M | +30.3% |
| +19.1% |
| Stockholders' Equity |
| $710.9M |
| -4.5% |